Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study

INTRODUCTION: Insulin is used to treat hyperglycaemia in critically ill patients but can cause hypoglycaemia, which is associated with poorer outcomes. In health glucose-dependent insulinotropic polypeptide (GIP) is a potent glucose-lowering peptide that does not cause hypoglycaemia. The objectives...

Descripción completa

Detalles Bibliográficos
Autores principales: Kar, Palash, Cousins, Caroline E, Annink, Christopher E, Jones, Karen L, Chapman, Marianne J, Meier, Juris J, Nauck, Michael A, Horowitz, Michael, Deane, Adam M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340673/
https://www.ncbi.nlm.nih.gov/pubmed/25613747
http://dx.doi.org/10.1186/s13054-014-0718-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340673/
https://www.ncbi.nlm.nih.gov/pubmed/25613747
http://dx.doi.org/10.1186/s13054-014-0718-3

Ejemplares similares